Henry Yau – Managing Director, HKU Clinical Trials Centre
Last Autumn, the Hong Kong government announced a plan to create a one-stop-shop clinical trial institute across the Greater Bay Area (GBACTI) as part of its plan to promote biomedical…
Address: 43rd Floor, Gloucester Tower, The Landmark, 15 Queen’s Road Central, Hong Kong
Tel: +852 2218 9100
Web: http://www.orrick.com/Offices/Hong-Kong/Pages/default.aspx
Hong Kong is uniquely positioned at the doorsteps of the world’s fastest growing major economy of the 21st century and the lawyers on Orrick’s China Team have been there since the first days those doors were opened. In 1972, Coudert Brothers was the first foreign law firm to open an office in Hong Kong and, in November 2005, the entire 25-lawyer office of Coudert joined Orrick, opening Orrick’s first of three China-focused offices. Orrick’s offices in Beijing and Shanghai opened in 2006 when most of Coudert’s lawyers in Beijing and Shanghai also joined Orrick. In addition to being first in Hong Kong, Coudert was the first foreign law firm to establish a permanent presence in Beijing (1979), the first foreign law firm to be approved by the Ministry of Justice to establish a law office in China (Beijing, 1992; with the receipt of license no. 001) and one of the first foreign law firms to open an office in Shanghai (2001).
For more than three decades, Orrick’s Hong Kong lawyers have been guiding the world’s most prominent businesses through many of the first and most complex commercial and financial transactions involving China, including:
* The Coca-Cola Company
* McDonald’s
* S.C. Johnson & Sons, Inc.
* Carrefour
* General Motors Corporation
* NEC Corporation
* Occidental Petroleum
Beyond China, the Hong Kong team’s experience extends throughout the Asia-Pacific region on significant transactions including the “London Club” of more than 60 commercial banks in a series of jumbo loans of more than $1.5 billion of U.S. dollar- and yen-denominated sovereign debt extended to the Republic of Indonesia; Telenor Ltd. (a Norwegian telecommunications company) in acquiring shares in two Thai telecommunications companies; foreign investors in a series of acquisitions and divestitures in the electric power generating sector in the Philippines; and structuring and advising many of the first hedge funds and private equity funds organized with investors from multiple jurisdictions for investment targets throughout the Asia-Pacific region.
International Reputation
The reputation of Orrick’s Hong Kong lawyers is well recognized by recent awards from leading global publications, including:
* M&A Deal of the Year
* Real Estate and Construction Deal of the Year
* Logistics Deal of the Year
Unique Qualifications
Orrick’s Hong Kong team is strongly positioned to assist local and international clients with sophisticated transactions that cross multiple jurisdictions. Orrick’s Hong Kong office provides clients with a unique combination of lawyers who are qualified in multiple jurisdictions, fluent in multiple languages, graduates of many of the world’s most well respected legal and business universities, experienced in business operations and management, and have served in government positions.
* Multiple Jurisdictions
Orrick’s Hong Kong lawyers have more than 30 years of experience handling corporate, commercial, securities, finance, litigation and arbitration matters under the laws of the multiple jurisdictions where local lawyers are qualified – Hong Kong, Australia, the United States, England and Wales.
* Multiple Language Capabilities
In addition to being qualified to practice in multiple jurisdictions, Orrick’s Hong Kong office also provides clients with lawyers who are fluent in multiple languages, including English, Cantonese, French, Korean, Mandarin and Putonghua.
* Legal Educations and Business Backgrounds
Lawyers in Orrick’s Hong Kong office have received graduate degrees (J.D./LL.B., LL.M., M.B.A., B.A. and B.S.) from well-known universities in the United States, the United Kingdom, Australia, China and Hong Kong, including Chinese University of Hong Kong, Columbia University, Fudan University (Shanghai), Harvard Law School, London School of Economics, New York Law School, Stanford Law School, University of California (Berkeley), University of Hong Kong, University of Melbourne, University of New South Wales, University of Southern California (Los Angeles), University of International Business and Economics (Beijing) and Yale College.
Orrick’s team of lawyers also includes lawyers with diverse backgrounds, including a lawyer who began advising foreign companies on China matters in 1980 as a Beijing-based business representative and consultant, a lawyer who practiced in California and Korea before moving to Hong Kong in 1993, a lawyer who worked for the Department of Justice of the Hong Kong Government, and a lawyer who held numerous Shenzhen-based management positions. The Hong Kong office is also staffed by Chinese and foreign consultants, legal assistants, trainee solicitors and translators.
Banking and Bank Regulatory Matters, Dispute Resolution, Emerging Companies and Venture Capital, Employment Law, Finance and Project Finance, Financial Markets, Intellectual Property, Internal Investigations, Life Sciences, Media and Entertainment, Mergers and Acquisitions, Private Equity, Investment Funds and Venture Capital, Real Estate Development and Finance, Restructuring, Securities, Tax
Last Autumn, the Hong Kong government announced a plan to create a one-stop-shop clinical trial institute across the Greater Bay Area (GBACTI) as part of its plan to promote biomedical…
VMS Group was founded in 2006 and since then has built close relationships with a handful of large anchor investors, including some of the largest families in Hong Kong. Apart…
Haematological oncologist Dr Raymond Liang, gives his take on the adoption and challenges of CAR-T therapy in Hong Kong, the necessity of collaboration with mainland China for patient referrals and…
Hong Kong Exchanges and Clearing Limited (HKEX) chief executive Nicolas Aguzin has stepped down after a term fraught with upheaval. Having survived COVID-19 isolation, under Aguzin HKEX was confronted with…
Although well-established as Asia’s leading financial services and trading hub, Hong Kong has never truly been globally competitive in the innovation and technology space, despite piecemeal initiatives to bolster its…
While much of PharmaBoardroom’s recent report on Hong Kong and the Greater Bay Area looks at how Hong Kong is attempting to position itself as a development and financing hub…
Hong Kong provides some of the best and most efficient healthcare in Asia, with Hong Kongers living to over 85 on average (compared to 83 in Singapore and 78 in…
A decade on from its launch, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative has made some significant wins but remains some way from fulfilling the vision of a fully…
2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to receive the funding it needs to progress. It…
Insighta, formed this year as a 50/50 joint venture between genomics-focused outfit Prenetics and one of the city’s most feted scientific sons, Professor Dennis Lo, is aiming to change the…
Almost a decade on from the establishment of a Phase I clinical trial centre in Hong Kong, the city continues to pursue a stronger positioning within the global clinical research…
Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on its established areas of finance and…
See our Cookie Privacy Policy Here